In particular, the TGFβ inhibitor peptide P144 (derived from the extracellular sequence of the human TGFβ type III receptor) successfully impaired tumor growth and increased survival of nude mice implanted with human glioblastoma xenografts [138]. The gene discussed is TGFB1; the disease is glioblastoma.